Invitrogen™ LV-MAX™ Lentiviral Packaging Mix

Description

LV-MAX Lentiviral Packaging Mix is an optimized single formulation containing a defined mixture of three packaging plasmids: pLP1, pLP2, and pLP/VSVG.

The LV-MAX Lentiviral Packaging Mix is a single, optimized set of packaging plasmids, designed to streamline and enhance the production of lentiviral vectors. This mix contains a defined combination of three essential packaging plasmids: pLP1, pLP2, and pLP/VSVG, which together supply the necessary structural and replication proteins in trans when expressed in HEK293-derived Viral Production Cells. This third-generation packaging system offers enhanced biosafety, as the Rev gene is supplied on a separate plasmid, independent of other lentiviral genes, thereby significantly reducing the likelihood of recombination and producing replication-competent lentiviral particles.

Key features of the LV-MAX Lentiviral Packaging Mix

• Optimized formulation—combines three packaging plasmids (pLP1, pLP2, and pLP/VSVG) into a single mix, saving process development time by minimizing the need to optimize plasmid ratios
• High titer—achieves high titers of lentiviral vectors when used with the LV-MAX Lentiviral Production System

Applications

• Gene therapy—ideal for the production of lentiviral vectors for gene therapy research and development
• Cell therapy—supports the generation of lentiviral vectors for cell therapy applications, facilitating seamless transition from bench to clinic
• Research and development—provides a reliable and scalable solution for viral vector production in various research settings

Specifications

• Product Type: Lentiviral Packaging Mix
• Sterility: Non-sterile
• Quantity: 1.5 mL
• Content And Storage: Store at -5 to -30°C. Ships on gel ice.